1403258-37-6

Basic information

• Product Name: 3-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzamide
• Synonyms: 3-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzamide
• CAS NO: 1403258-37-6
• Molecular Weight: 494.404
• Mol File: 1403258-37-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzamide(1403258-37-6)
• EPA Substance Registry System: 3-bromo-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzamide(1403258-37-6)

Safety Data

• Hazardous Substances Data: 1403258-37-6(Hazardous Substances Data)

Upstream product

• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 75-07-0 acetaldehyde 
• 771579-27-2 3-(aminomethyl)-4,6-dimethyl-1,2-dihydropyridin-2-one 
• 1403258-36-5 3-bromo-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzoic acid 
• 1403258-35-4 methyl 3-bromo-5-[ethyl(oxan-4-yl)amino]-2-fluoro-6-methylbenzoate 
• 1403258-34-3 methyl 3-bromo-2-fluoro-6-methyl-5-[(oxan-4-yl)amino]benzoate 
• 1403258-33-2 methyl 3-amino-5-bromo-6-fluoro-2-methylbenzoate 
• 1403258-32-1 methyl 3-bromo-2-fluoro-6-methyl-5-nitrobenzoate 
• 1403258-31-0 3-bromo-2-fluoro-6-methyl-5-nitrobenzoic acid 
• 1079992-96-3 (6-fluoro-2-methyl-3-nitrobenzoic acid) 
• 90259-27-1 2-fluoro-6-methylbenzoic acid 

Downstream Products

• 1403256-01-8 N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-fluoro-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide 

Relevant articles and documents

Preparation Method for Amide Compounds and Use Thereof in Medical Field

Provided are a preparation method for amide compounds and use thereof in medical field. Specifically, provided are small molecule amide compounds. Such compounds are inhibitors of enhancer homolog 2 (EZH2) of Zeste gene, and can be used for preventing and/or treating related diseases mediated by EZH2, including tumors, myeloproliferative diseases or autoimmune diseases.